Newsroom | 9856 results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), today celebrated the grand opening of the Roche Genentech Innovation Center Boston. The center focuses on work in cardiovascular, renal and metabolic (CVRM) diseases, and expands Roche and Genentech’s U.S. research presence in one of the world’s leading life sciences communities. Located at Harvard’s Enterprise Research Campus in Allston, the Roche Genentech Innovation Center Bosto...

CAMBRIDGE, Mass. & MCCOMB, Miss.--(BUSINESS WIRE)--Royal Philips, a global leader in health technology and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of Southwest Health, today announced that the hospital has installed the first Philips Rembra CT system for acute and high-demand imaging environments in the United States. The new system is designed to support the McComb hospital’s high-demand emergency imaging environment with the goal of expanding local acces...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Pilot, North America’s largest network of travel centers, is celebrating the positive impact its guests and team members have collectively made over the last nine years, raising nearly $11.5 million in support of the American Heart Association. This achievement reflects the power of community action and Pilot’s commitment to safety, uniting people in the fight against heart disease and stroke to help save and improve lives. To celebrate this milestone, Pilot j...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced highlights from the first patient enrolled in the Company’s study evaluating its next-generation vCLAS™ Ultra Ultra-Low Temperature Ablation (“ULTA”) Ventricular Ablation System. The study is designed to support a Premarket Approval (“PMA”) supplement to the Company’s PMA f...

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWOMEN today announced that Maria Sainz, President and CEO of Hyperfine, Inc., has been named the recipient of its 2026 Ferolyn Powell Leadership Award, and that Beverly Tang, co-founder and CEO of Starlight Cardiovascular, has received MedtechWOMEN’s first-ever Rising Star Award. Both leaders were recognized at the annual MedtechVISION Annual Conference at the Rosewood Sand Hill in Menlo Park, Calif. Since 2016, the Ferolyn Powell Leadership Award has...

MIAMI & PHILADELPHIA--(BUSINESS WIRE)--OpenEvidence, the most widely used medical AI and clinical decision-making tool among U.S. physicians, and Penn Medicine today announced a global partnership to bring AI-powered clinical decision support to Penn Medicine's more than 10,000 clinicians across its seven-hospital U.S. health system. That clinical decision support will also extend to low and middle income countries through the Botswana-UPenn Partnership (BUP). Building on Penn Medicine’s deep c...

BOSTON--(BUSINESS WIRE)--SC Therapeutics, with University North Carolina, Imperial College London, and Boston University, announced publication on Tuesday in Nature Scientific Reports of results from a multi-institutional study indicating that the aridity inherent in heatwaves increases cough hypersensitivity in human airways by collapsing mucus onto cilia in a manner common to chronic respiratory diseases, such as cystic fibrosis, and asthma. The researchers find that alkaline aerosols of magn...

MILWAUKEE--(BUSINESS WIRE)--Retham Technologies, Inc. today announced the initial close of its $1.5 million seed financing, led by Talents Fund, with participation from Golden Angels Investors and Milwaukee Venture Partners. The financing will advance HITDx™, Retham's functional diagnostic assay for heparin-induced thrombocytopenia (HIT). HIT is a potentially life-threatening immune reaction to heparin, one of the world's most widely used blood thinners. The condition can cause dangerous blood...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that 13 hospitals across its network earned recognition in U.S. News & World Report’s 2026-2027 Best Hospitals rankings, the publication’s 37th annual assessment of hospital quality. The honors include a Best Regional Hospital designation, regional specialty rankings and 34 High Performing ratings across procedures and conditi...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s first investigational RNA interference (RNAi) therapeutic dimer being developed as a potential treatment for atherosclerotic cardiovascular disease (ASCVD) due to mixed hyperlipidemia. ARO-DIMER-PA is designed to silence expression of both proprotein convertase subtilisin kexin 9 (PCSK9) and apolipoprotein C3 (APOC...